Correlation Between Diamyd Medical and CVR Medical
Can any of the company-specific risk be diversified away by investing in both Diamyd Medical and CVR Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Diamyd Medical and CVR Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Diamyd Medical AB and CVR Medical Corp, you can compare the effects of market volatilities on Diamyd Medical and CVR Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Diamyd Medical with a short position of CVR Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Diamyd Medical and CVR Medical.
Diversification Opportunities for Diamyd Medical and CVR Medical
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Diamyd and CVR is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Diamyd Medical AB and CVR Medical Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CVR Medical Corp and Diamyd Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Diamyd Medical AB are associated (or correlated) with CVR Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CVR Medical Corp has no effect on the direction of Diamyd Medical i.e., Diamyd Medical and CVR Medical go up and down completely randomly.
Pair Corralation between Diamyd Medical and CVR Medical
If you would invest 108.00 in Diamyd Medical AB on August 31, 2024 and sell it today you would lose (1.00) from holding Diamyd Medical AB or give up 0.93% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Diamyd Medical AB vs. CVR Medical Corp
Performance |
Timeline |
Diamyd Medical AB |
CVR Medical Corp |
Diamyd Medical and CVR Medical Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Diamyd Medical and CVR Medical
The main advantage of trading using opposite Diamyd Medical and CVR Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Diamyd Medical position performs unexpectedly, CVR Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CVR Medical will offset losses from the drop in CVR Medical's long position.Diamyd Medical vs. Moderna | Diamyd Medical vs. Superior Plus Corp | Diamyd Medical vs. NMI Holdings | Diamyd Medical vs. Origin Agritech |
CVR Medical vs. Air New Zealand | CVR Medical vs. Commercial Vehicle Group | CVR Medical vs. Wizz Air Holdings | CVR Medical vs. Enter Air SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |